InvestorsHub Logo
Followers 29
Posts 1838
Boards Moderated 0
Alias Born 09/12/2010

Re: 1~Eye~Jack!! post# 75441

Wednesday, 06/05/2013 10:05:35 AM

Wednesday, June 05, 2013 10:05:35 AM

Post# of 158400
The Timeline is not Correct!

www.otcmarkets.com/stock/BMSN/financials#

Goto Financials ----> Balance Sheet ----> Annual

Look at the Header - These are filed at end Fiscal Year!!

Fiscal year is What a Companies go off of not Calendar year (although in some cases may be the same thing)

Fiscal Year Ending ----> Sept 30th

This Puts actual time Line as Follows :

Q1= OCT NOV DEC
Q2= JAN FEB MAR
Q3= APR MAY JUN
Q4= JUL AUG SEP


Response to FDA questions: Q3 2013
Initiate HemaXellerate trial: Q4 2013 === IF FDA IND Gets Approval!
Complete HemaXellerate trial: Q4 2014-Q2 2015
In license Min technology: Q2 2013
File IND on Min technology: Q4 2013
Initiate clinical trial on Min technology: Q4 2013
Complete clinical trial on Min technology: Q4 2014-Q2 2015

Again The Timeline in the Quote Below is not correct! Correct information is above!

~~~Actual BMSN Co. Timeline!

Response to FDA questions: Q3 2013
Initiate HemaXellerate trial: Q4 2013 === IF FDA IND Gets Approval!
Complete HemaXellerate trial: Q4 2014-Q2 2015
In license Min technology: Q2 2013
File IND on Min technology: Q4 2013
Initiate clinical trial on Min technology: Q4 2013
Complete clinical trial on Min technology: Q4 2014-Q2 2015
---
RedGoose

Quote:
--------------------------------------------------------------------------------
Actually it doesnt clearly say that at all. It says they will respond to FDA questions in regards to the IND hold in Q3.

The way I took this info from the day it came out was they will respond to the FDA IND hold by Q3 which means no later than Sept 30th but as early as July 1st. This means they will "RESPOND" to the FDA. Technically they could respond to the FDA on Sept 31st and still be in the time line. Nothing about the IND to be approved in Q3 or to hear anything from the FDA.

They will initiate trials in Q4 which means they are looking for the FDA to finally approve Q3 response to the IND in Q4 which would in turn allow trials to begin no later than Dec 31st but as early as Oct 1st. Again think of it as they could receive FDA approval Dec 30th and begin trials Dec 31st and still fall in the time line.

I am hoping for the best in all scenarios but you have to expect the worse as far as these time lines go and be patient. A lot of folks will bail if their own expectations are not met if they cant comprehend worse possible scenarios as far as dates are concerned.
--------------------------------------------------------------------------------



Q1= JAN FEB MAR
Q2= APR MAY JUN
Q3= JUL AUG SEP
Q4= OCT NOV DEC

Pian0wire

Quote:
--------------------------------------------------------------------------------
Hey Red! Yes, you are correct. Wasn't reading it right. And yes, people will need to exercise patience here.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.